Correlation Between Molecular Templates and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Crispr Therapeutics AG, you can compare the effects of market volatilities on Molecular Templates and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Crispr Therapeutics.
Diversification Opportunities for Molecular Templates and Crispr Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Molecular and Crispr is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Molecular Templates i.e., Molecular Templates and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Templates and Crispr Therapeutics
Given the investment horizon of 90 days Molecular Templates is expected to under-perform the Crispr Therapeutics. In addition to that, Molecular Templates is 3.18 times more volatile than Crispr Therapeutics AG. It trades about -0.01 of its total potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.02 per unit of volatility. If you would invest 4,899 in Crispr Therapeutics AG on August 30, 2024 and sell it today you would earn a total of 185.00 from holding Crispr Therapeutics AG or generate 3.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Molecular Templates vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Molecular Templates |
| Crispr Therapeutics |
Molecular Templates and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Crispr Therapeutics
The main advantage of trading using opposite Molecular Templates and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Molecular Templates vs. Bright Minds Biosciences | Molecular Templates vs. HP Inc | Molecular Templates vs. Intel | Molecular Templates vs. Chevron Corp |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |